Tags » Dyslipidemia

Atorvastatin (Lipitor®) - HMG-CoA Reductase Inhibitor


Atorvastatin is statin-class drug commonly prescribed for the treatment of dyslipidemias and for the prevention of ischemic cardiovascular events.  It works by inhibiting hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase, a key enzyme in the cholesterol biosynthetic pathway.  313 more words

Cardiovascular Drugs

PCSK9 Inhibitors’ Battle for Reimbursement: Germany’s Decision and Implications in Other Countries

By Anastasios Pappas, Senior Analyst (Health Advances GmbH)


  • After having been assigned no incremental benefit vs standard of care, both approved PCSK9 inhibitors were initially explicitly excluded from prescription in Germany…
  • 568 more words

Interventions to Reduce Cardiovascular Risk in Children with Type 1 Diabetes


Jose A. Canas, Samuel S. Gidding and Nelly Mauras*


Background: Despite recent advances in improved glycemic control, the magnitude of lifetime risk from premature cardiovascular disease in individuals with type 1 diabetes remains at least 10 fold higher than in the general population. 92 more words